Key Market Indicator:
F&G: 49
25.158,75 NASDAQ · 49.141,50 DOW · 6.835,05 S&P · 4.825,03 Gold · 64,57 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Globe Newswire
13.09.2024
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron completes share buy-back program
Article
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 September 2024 – 6PM CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.09.2024
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th
Article
News Preview
Press Release – No. 9 / 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
13.09.2024
ISIN: SE0020353928
Moberg Pharma AB
MOB
LISTED
STO
Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients
Article
News Preview
STOCKHOLM, Sept. 13, 2024 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announces that the company has received information about clinical cure in a subset of patients in the ongoing North American Phase 3 study for MOB-015 against nail fungus. The number of patients who have achieved clinical cure in this blinded subset of patients is lower than t...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
13.09.2024
ISIN: DK0060055861
Chemometec A/S
CHEMM
LISTED
CPH
Notification of managers’ transactions
Article
News Preview
ANNOUNCEMENT NO. 274...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
12.09.2024
ISIN: US45258D1054
Immunocore Holdings plc
IMCR
LISTED
NASDAQ
Immunocore to present at the 2024 Cantor Global Healthcare Conference
Article
News Preview
Immunocore to present at the 2024 Cantor Global Healthcare Conference...
Themefolio
Profiler
Peergroup
© PR Newswire
12.09.2024
ISIN: AU0000165375
Clarity Pharmaceuticals Ltd
CU6
LISTED
ASX
SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort
Article
News Preview
Highlights Cohort 4 of the SECuRE trial is the first to assess multiple cycles of 67Cu-SAR-bisPSMA at the highest dose of 12GBq.The Safety Review Committee (SRC) assessed early data from the first 3 participants in cohort 4 who received 2 doses of 67Cu-SAR-bisPSMA. Two of these participants had completed the dose limiting toxicity (DLT) period an...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2024
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
Article
News Preview
Company announcement – No. 45 / 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2024
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a patient-facing app, olivia, an AI-enabled personal health concierge to empower individuals to holistically organize, manage, and proactively take control of their own health data. olivi...
Themefolio
Profiler
Peergroup
© PR Newswire
12.09.2024
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi® and Enable Injections announce agreement to develop and distribute Aspaveli® in combination with enFuse® in Sobi territories
Article
News Preview
STOCKHOLM, Sept. 12, 2024 /PRNewswire/ -- Sobi® (STO: SOBI) and Enable Injections, Inc. (Enable) today announced an international development and distribution agreement across Sobi territories for the enFuse® Injector, for the subcutaneous delivery of Aspaveli® (pegcetacoplan).  The enFuse Injector, to be produced by Enable and distributed by So...
Themefolio
Profiler
Peergroup
© PR Newswire
12.09.2024
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow
Article
News Preview
Showcasing at EURETINA 2024: ZEISS will highlight new surgical innovations and artificial intelligence (AI) tools for retinal patient care, helping doctors diagnose and treat patients efficiently and effectively:  THE FUTURE OF VITREORETINAL SURGERY: Demonstrating the ZEISS ARTEVO 850 3D digital visualization system, Single-use Lenses for ZEISS...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2024
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
Article
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent survey of over 100 professionals engaged in oncology drug development to understand the current state of emerging oncology treatment development, including the associated clinical trial dynamics. Respond...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Trading by management and close relations of management
Article
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
12.09.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation
Article
News Preview
COPENHAGEN, Denmark, September 12, 2024 – Bavarian Nordic A/S (OMX: BAVA), the vaccine manufacturer of MVA-BN®, the only approved non-replicating smallpox and mpox vaccine (marketed as JYNNEOS®, IMVAMUNE® and IMVANEX®) today provided an update of its supply and manufacturing activities in support of the ongoing mpox outbreak....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ISIN: US04351P1012
Ascendis Pharma A/S
ASND
LISTED
NASDAQ
Ascendis Pharma Receives Orphan Drug Exclusivity in the U.S. for YORVIPATH® (Palopegteriparatide) for the Treatment of Hypoparathyroidism in Adults
Article
News Preview
–   U.S. FDA Orphan Drug exclusivity provides seven years of market exclusivity for YORVIPATH in the United States for the treatment of hypoparathyroidism in adults...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ISIN: DK0060055861
Chemometec A/S
CHEMM
LISTED
CPH
Guidance for the 2024/25 financial year
Article
News Preview
ANNOUNCEMENT NO. 272...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ISIN: ES0167733015
Oryzon Genomics SA
ORY
LISTED
BME
ORYZON Receives “Intention to Grant” Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality Disorder
Article
News Preview
From the European Patent Office From the European Patent Office...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2024
ISIN: SE0000202624
Getinge AB
GETI B
LISTED
STO
Getinge completes the acquisition of Paragonix Technologies
Article
News Preview
Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc. GOTHENBURG, Sweden, Sept. 11, 2024 /PRNewswire/ -- On August 22, 2024, Getinge announced that it had entered into an agreement to acquire Paragonix Technologies, Inc., a leading U.S. company in organ transport products and servic...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Trading by management and close relations of management
Article
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Inside information: Orion upgrades full-year outlook for 2024
Article
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION11 SEPTEMBER 2024 at 09:30 EEST...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production
Article
News Preview
Louvain-la-Neuve, Belgium, September 11, 2024 – IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, is pleased to share the below press release from its joint venture PanTera, which is focussed on the production of actinium-225, a novel radioisotope used in a new class of targeted treatments for cancer....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Article
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
Article
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to help plan and perform total ankle replacement (TAR) procedures. Engineered using 3D Systems’ VSP® surgical planning workflows, all-in-one TOTAL ANKLE Pati...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
ISIN: IE000LK2BOB4
Mural Oncology PLC
MURA
LISTED
NASDAQ
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
Article
News Preview
Company will provide clinical overview and update on late-stage clinical candidate, nemvaleukin alfa, and overview of IL-18 pipeline program...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2024
ISIN: CA60255C8850
Definium Therapeutics, Inc.
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 70,000 common shar...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2024
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
Article
News Preview
Company announcement – No. 44 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.09.2024
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron’s share buy-back program: Weekly update
Article
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 September 2024 – 6PM CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.09.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Article
News Preview
COPENHAGEN, Denmark, September 6, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.09.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Major shareholder announcement
Article
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2024
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration
Article
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) and Shilpa Medicare Limited (“Shilpa”) announced U.S. Food and Drug Administration (FDA) approval of BORUZU™, a new presentation of bortezomib for ready-to-use subcutaneous administration or intravenous (IV) administration. This new ready-to-use oncology product reduces the co...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Article
News Preview
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
ISIN: US74039M3097
Predictive Oncology, Inc.
POAI
LISTED
NASDAQ
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Article
News Preview
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is scheduled to deliver a virtual presentation and host investor one-on-one meetings at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9th through 11th in New York...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Article
News Preview
LUND, Sweden, Sept. 5, 2024 /PRNewswire/ -- Hansa Biopharma today announced that Søren Tulstrup will participate in a Fireside chat hosted by Douglas Tsao, Managing Director and Senior Financial Analyst at H.C. Wainwright on Wednesday, September 11 at 8:00 AM EST. Mr. Tsao's research focuses on biopharmaceuticals and specialty pharmaceuticals. Th...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Article
News Preview
LUND, Sweden, Sept. 5, 2024 /PRNewswire/ -- Hansa Biopharma today announced that Søren Tulstrup will participate in a Fireside chat hosted by Douglas Tsao, Managing Director and Senior Financial Analyst at H.C. Wainwright on Wednesday, September 11 at 8:00 AM EST. Mr. Tsao's research focuses on biopharmaceuticals and specialty pharmaceuticals. Th...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo
Article
News Preview
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the first doses of its mpox vaccine, MVA-BN®, also known as JYNNEOS®, has arrived today in the Democratic Republic of Congo (DRC). Additional shipments to the DRC are planned within the next week adding to a total of more than 250,000 vaccines donated by t...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
ISIN: DK0060336014
Novozymes A/S
NSIS B
LISTED
CPH
Major shareholder announcement
Article
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Article
News Preview
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 7,164,460 as a consequence of employees’ exercise of warrants....
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2024
ISIN: GB0002074580
Genus PLC
GNS
LISTED
LSE
Genus plc Preliminary Results for the Year Ended 30 June 2024
Article
News Preview
Genus (LSE:GNS), a leading global animal genetics company, today announces its preliminary results for the year ended 30 June 2024. The full report has been made available on the investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights in a pre-recorded webcast at 7:01 AM GMT, 2.01 ES...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
ISIN: DK0010272632
GN Store Nord A/S
GN
LISTED
CPH
Trading in GN Store Nord shares by board members, executives and associated persons
Article
News Preview
Trading in GN Store Nord shares by board members, executives and associated persons...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2024
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Listed on the MDAX for the first time
Article
News Preview
Promotion for SCHOTT Pharma: Listed on the MDAX for the first time SCHOTT Pharma to join the 90 most important shares listed on the Frankfurt stock exchange as of September 23, 2024 MDAX promotion proves confidence in the company’s business model, strategic focus and ideal market position   The shares of SCHOTT Pharma AG & Co. KGaA, a global......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2024
ISIN: DE000A3ENQ51
SCHOTT Pharma AG & Co KgaA
1SXP
LISTED
XETR
Erstmalige Aufnahme in den MDAX
Article
News Preview
Aufstieg für SCHOTT Pharma: Erstmalige Aufnahme in den MDAX SCHOTT Pharma gehört ab dem 23. September 2024 zu den 90 wichtigsten Aktien an der Frankfurter Wertpapierbörse MDAX-Aufstieg belegt Vertrauen in das Geschäftsmodell, die strategische Ausrichtung und die optimale Marktposition des Unternehmens Die Aktien der SCHOTT Pharma AG & Co. KGa......
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2024
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN und Lilly kooperieren bei der Entwicklung eines QIAstat-Dx IVD-Panels zur Identifizierung von Patienten mit erhöhtem Risiko für Alzheimererkrankungen
Article
News Preview
QIAGEN entwickelt erstes QIAstat-Dx IVD-Panel für neurodegenerative Anwendungen // Neues QIAstat-Dx-Panel identifiziert APOE-Genotypen, die als einer von vielen Faktoren eine Rolle bei der Einschätzung des Risikos einer Alzheimererkrankung spielen können // Kooperation sieht Markteinführung des ersten kommerziell erhältlichen IVD-Kits für die APOE-...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2024
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus Announces Real World Data Collaboration with BioNTech
Article
News Preview
Tempus AI, Inc. (NASDAQ: TEM, “Tempus”), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a multi-year collaboration with BioNTech SE (Nasdaq: BNTX, “BioNTech”), a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. This collab...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2024
ISIN: CA23256X4075
Cybin Inc.
HELP
LISTED
NASDAQ
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Article
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a firesid...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2024
ISIN: CA60255C8850
Definium Therapeutics, Inc.
DFTX
LISTED
NASDAQ
MindMed to Participate in September Investor Conferences
Article
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences: H.C. Wainwright 26th Annual Global Investm...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
ISIN: GB00BN4HT335
Indivior PLC
INDV
LISTED
NASDAQ
Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder
Article
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). Primary and Secondary End Points of the Study were Not Met Indivior Does Not Currently Expect to Exercise AEF0117 Option SLOUGH...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
ISIN: GB00BN4HT335
Indivior PLC
INDV
LISTED
NASDAQ
Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder
Article
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). Primary and Secondary End Points of the Study were Not Met Indivior Does Not Currently Expect to Exercise AEF0117 Option SLOUGH...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ISIN: US04351P1012
Ascendis Pharma A/S
ASND
LISTED
NASDAQ
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
Article
News Preview
Proceeds to support continued development and commercialization of Endocrine Rare Disease products, including the YORVIPATH® U.S. commercial launch, and general corporate purposes Proceeds to support continued development and commercialization of Endocrine Rare Disease products, including the YORVIPATH® U.S. commercial launch, and general corporate...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN N.V. announces conversion price of new net share settled convertible bonds
Article
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. NOT FOR DISTRIBUTION TO ANY U.S. PERSON. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ISIN: US04351P1012
Ascendis Pharma A/S
ASND
LISTED
NASDAQ
Ascendis Pharma Reports Second Quarter 2024 Financial Results
Article
News Preview
COPENHAGEN, Denmark, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the second quarter ended June 30, 2024, and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
Article
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ISIN: NL0012169213
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN N.V. announces successful placement of new net share settled convertible bonds
Article
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. NOT FOR DISTRIBUTION TO ANY U.S. PERSON. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ISIN: SE0010441584
Calliditas Therapeutics AB
CALTX
LISTED
STO
Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
Article
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas Therapeutics"), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the extraordinary general meeting on Monday 30 September 2024 at 12:00 p.m. CEST at Advokatfirman Vinge's premises on Smålandsgatan 20, SE-111 46, St...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ISIN: SE0010441584
Calliditas Therapeutics AB
CALTX
LISTED
STO
Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
Article
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- Following the announcement by Asahi Kasei Corporation ("Asahi Kasei") on September 2, 2024 that it controls more than 90 percent of the outstanding shares of Calliditas Therapeutics AB (Nasdaq: CALT) ("Calliditas" or the "Company"), and declared its offers to purchase all of the outstanding Common Shares a...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ISIN: SE0010441584
Calliditas Therapeutics AB
CALTX
LISTED
STO
Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
Article
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- Following the announcement by Asahi Kasei Corporation ("Asahi Kasei") on September 2, 2024 that it controls more than 90 percent of the outstanding shares of Calliditas Therapeutics AB (Nasdaq: CALT) ("Calliditas" or the "Company"), and declared its offers to purchase all of the outstanding Common Shares a...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2024
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON plc to Present at the Baird 2024 Global Healthcare Conference
Article
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, 2024 at 3:45 pm ET. Any changes to this event and links to the live webcast will be posted on the Invest...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ISIN: SE0000736415
Orexo AB
ORX
LISTED
STO
Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024
Article
News Preview
UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities' 15th Annual Healthcare Conference, that takes place on September 19, at Downtown Camper by Scandic, Brunkebergstorg 9, Stockholm, Sweden. On the day, between 2:25-2:45 CET (room Event Smal...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ISIN: SE0000736415
Orexo AB
ORX
LISTED
STO
Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024
Article
News Preview
UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities' 15th Annual Healthcare Conference, that takes place on September 19, at Downtown Camper by Scandic, Brunkebergstorg 9, Stockholm, Sweden. On the day, between 2:25-2:45 CET (room Event Smal...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ISIN: SE0000135485
RaySearch Laboratories AB (publ)
RAY B
LISTED
STO
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Article
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Iridium Network in Belgium has treated its first patient using RaySearch's oncology information system RayCare®* together with a Varian TrueBeam®** linear accelerator. The treatment was successfully carried out on September 2, 2024. Since its es...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ISIN: DK0010272632
GN Store Nord A/S
GN
LISTED
CPH
Trading in GN Store Nord shares by board members, executives and associated persons
Article
News Preview
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them....
Themefolio
Profiler
Peergroup
© EQS Newswire
03.09.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec gibt Veränderung im Vorstand bekannt
Article
News Preview
  Dr. Matthias Evers tritt mit Wirkung zum 01. Oktober 2024 als Chief Business Officer zurück Verantwortlichkeiten werden auf andere Vorstandsressorts verteilt   Hamburg, 03. September 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, dass ihr Chief Business Officer......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Wednesday, 21.01.2026, Calendar Week 04, 21st day of the year, 344 days remaining until EoY.